- Home
- GRFS vs SGHC Comparison
GRFS vs SGHC Comparison
Compare GRFS & SGHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRFS
- SGHC
- Stock Information
- Founded
- GRFS 1940
- SGHC 2020
- Country
- GRFS Spain
- SGHC Guernsey
- Employees
- GRFS N/A
- SGHC N/A
- Industry
- GRFS Biotechnology: Pharmaceutical Preparations
- SGHC Services-Misc. Amusement & Recreation
- Sector
- GRFS Health Care
- SGHC Consumer Discretionary
- Exchange
- GRFS Nasdaq
- SGHC Nasdaq
- Market Cap
- GRFS 7.2B
- SGHC 6.0B
- IPO Year
- GRFS 2006
- SGHC N/A
- Fundamental
- Price
- GRFS $9.74
- SGHC $11.78
- Analyst Decision
- GRFS Hold
- SGHC Strong Buy
- Analyst Count
- GRFS 1
- SGHC 8
- Target Price
- GRFS $10.30
- SGHC $14.75
- AVG Volume (30 Days)
- GRFS 487.9K
- SGHC 4.0M
- Earning Date
- GRFS 01-01-0001
- SGHC 11-05-2025
- Dividend Yield
- GRFS 1.47%
- SGHC 1.32%
- EPS Growth
- GRFS 132.60
- SGHC 1999.69
- EPS
- GRFS 0.53
- SGHC 0.29
- Revenue
- GRFS $8,744,226,659.00
- SGHC $2,230,781,944.00
- Revenue This Year
- GRFS $5.61
- SGHC $23.24
- Revenue Next Year
- GRFS $6.70
- SGHC $7.39
- P/E Ratio
- GRFS $24.36
- SGHC $41.21
- Revenue Growth
- GRFS 9.32
- SGHC 37.19
- 52 Week Low
- GRFS $6.19
- SGHC $3.44
- 52 Week High
- GRFS $11.14
- SGHC $13.71
- Technical
- Relative Strength Index (RSI)
- GRFS 44.50
- SGHC 46.34
- Support Level
- GRFS $9.65
- SGHC $12.36
- Resistance Level
- GRFS $10.06
- SGHC $13.71
- Average True Range (ATR)
- GRFS 0.18
- SGHC 0.73
- MACD
- GRFS -0.02
- SGHC -0.10
- Stochastic Oscillator
- GRFS 26.15
- SGHC 32.28
About GRFS Grifols S.A.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
About SGHC Super Group (SGHC) Limited
Super Group (SGHC) Ltd is a holding company that operates online sports betting and gaming businesses. The company's reportable segments are Betway, Spin, and Other. A majority of its revenue is generated from the Betway segment, which is a single-brand online sports betting and casino offering with licenses to operate throughout Europe, the Americas, and Africa. Spin is the company's multi-brand online casino offering, having a diverse portfolio of casino brands such as Jackpot City, Spin Casino, Dream Bingo, Mirror Bingo, etc., designed to be culturally relevant globally while aiming to offer a wide range of casino products. Geographically, the company generates maximum revenue from Africa and Middle East, followed by North America, Europe, Asia-Pacific, and South/Latin America.